These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 10937516)

  • 1. Effect of the antiplatelet drug dilazep dihydrochloride on urinary podocytes in patients in the early stage of diabetic nephropathy.
    Nakamura T; Ushiyama C; Shimada N; Sekizuka K; Ebihara I; Hara M; Koide H
    Diabetes Care; 2000 Aug; 23(8):1168-71. PubMed ID: 10937516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Silent cerebral infarction in patients with type 2 diabetic nephropathy. Effects of antiplatelet drug dilazep dihydrochloride.
    Nakamura T; Kawagoe Y; Matsuda T; Ueda Y; Ebihara I; Koide H
    Diabetes Metab Res Rev; 2005; 21(1):39-43. PubMed ID: 15386824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical effect of the anti-platelet drug, dilazep dihydrochloride, in patients at the microalbuminuric stage of diabetic nephropathy--a multi-center study.
    Koide H; Totsuka Y; Sugisaki T; Kitajima T; Ohmori Y; Kuriyama S; Oi K; Isogai S; Ohi H; Tomino Y
    Nihon Jinzo Gakkai Shi; 1995 Nov; 37(11):644-8. PubMed ID: 8583701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary excretion of podocytes in patients with diabetic nephropathy.
    Nakamura T; Ushiyama C; Suzuki S; Hara M; Shimada N; Ebihara I; Koide H
    Nephrol Dial Transplant; 2000 Sep; 15(9):1379-83. PubMed ID: 10978394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dilazep hydrochloride, an antiplatelet drug, prevents progression of diabetic nephropathy in Otsuka Long-Evans Tokushima fatty rats.
    Yamagishi S; Koga K; Inagaki Y; Amano S; Okamoto T; Takeuchi M
    Drugs Exp Clin Res; 2002; 28(6):221-7. PubMed ID: 12776575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Podocyturia parallels proximal tubule dysfunction in type 2 diabetes mellitus patients independently of albuminuria and renal function decline: A cross-sectional study.
    Petrica L; Vlad M; Vlad A; Gluhovschi G; Gadalean F; Dumitrascu V; Popescu R; Gluhovschi C; Matusz P; Velciov S; Bob F; Ursoniu S; Vlad D
    J Diabetes Complications; 2017 Sep; 31(9):1444-1450. PubMed ID: 28161386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of antiplatelet drug dilazep dihydrochloride on anionic sites and extracellular matrix (ECM) components in glomerular basement membrane of STZ-induced diabetic rats.
    Yamamoto M; Fukui M; Kuramoto T; Kabuki K; Tomino Y
    J Clin Lab Anal; 1995; 9(6):380-6. PubMed ID: 8587006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of dilazep dihydrochloride on urinary albumin excretion in patients with autosomal dominant polycystic kidney disease.
    Nakamura T; Ushiyama C; Takahashi Y; Tanaka A; Shimada N; Ebihara I; Koide H
    Nephron; 2001 May; 88(1):80-2. PubMed ID: 11340355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pioglitazone reduces urinary podocyte excretion in type 2 diabetes patients with microalbuminuria.
    Nakamura T; Ushiyama C; Osada S; Hara M; Shimada N; Koide H
    Metabolism; 2001 Oct; 50(10):1193-6. PubMed ID: 11586492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of pitavastatin on urinary liver-type fatty acid-binding protein levels in patients with early diabetic nephropathy.
    Nakamura T; Sugaya T; Kawagoe Y; Ueda Y; Osada S; Koide H
    Diabetes Care; 2005 Nov; 28(11):2728-32. PubMed ID: 16249547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary podocalyxin is an early marker for podocyte injury in patients with diabetes: establishment of a highly sensitive ELISA to detect urinary podocalyxin.
    Hara M; Yamagata K; Tomino Y; Saito A; Hirayama Y; Ogasawara S; Kurosawa H; Sekine S; Yan K
    Diabetologia; 2012 Nov; 55(11):2913-9. PubMed ID: 22854890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of dilazep on urinary protein excretion in spontaneous diabetic Chinese hamster.
    Morikawa A; Eto M; Makino I
    Nephron; 1993; 65(1):125-32. PubMed ID: 8413770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The effects and mechanism of Tripterygium wilfordii Hook F combination with irbesartan on urinary podocyte excretion in diabetic nephropathy patients].
    Ma RX; Zhao N; Zhang W
    Zhonghua Nei Ke Za Zhi; 2013 Jun; 52(6):469-73. PubMed ID: 24059992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of urokinase on preservation of renal function in patients with diabetic nephropathy.
    Sakai H; Watanabe S; Inoue I; Tanaka K; Yagame M; Machimura H; Kaneshige H; Nomoto Y
    J Diabet Complications; 1991; 5(2-3):95-7. PubMed ID: 1770066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of urinary podocalyxin in early diagnosis of diabetic nephropathy.
    Kostovska I; Trajkovska KT; Cekovska S; Topuzovska S; Kavrakova JB; Spasovski G; Kostovski O; Labudovic D
    Rom J Intern Med; 2020 Dec; 58(4):233-241. PubMed ID: 32780718
    [No Abstract]   [Full Text] [Related]  

  • 16. The effect of pancreatic elastase on diabetic nephropathy.
    Nagai T
    Diabetes Res Clin Pract; 1994 Jul; 24(3):161-5. PubMed ID: 7988347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urine synaptopodin excretion is an important marker of glomerular disease progression.
    Kwon SK; Kim SJ; Kim HY
    Korean J Intern Med; 2016 Sep; 31(5):938-43. PubMed ID: 27604800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of pancreatic elastase on diabetic nephropathy.
    Nagai T; Tomizawa T; Mori M
    Diabetes Care; 1993 Aug; 16(8):1214-5. PubMed ID: 8375257
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of angiotensin-converting enzyme inhibitor, angiotensin II receptor antagonist and calcium antagonist on urinary podocytes in patients with IgA nephropathy.
    Nakamura T; Ushiyama C; Suzuki S; Hara M; Shimada N; Sekizuka K; Ebihara I; Koide H
    Am J Nephrol; 2000; 20(5):373-9. PubMed ID: 11092994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of urinary biomarkers as a diagnostic tool for early diabetic nephropathy in patients with type 2 diabetes mellitus.
    Vijay S; Hamide A; Senthilkumar GP; Mehalingam V
    Diabetes Metab Syndr; 2018 Sep; 12(5):649-652. PubMed ID: 29673928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.